BACKGROUND: The Women's Health Initiative dietary modification (DM) trial provided suggestive evidence of a benefit of a low-fat dietary pattern on breast cancer risk, with stronger evidence among women whose baseline diet was high in fat. Single nucleotide polymorphisms (SNP) in the FGFR2 gene relate strongly to breast cancer risk and could influence intervention effects. METHODS:All 48,835 trial participants were postmenopausal and ages 50 to 79 years at enrollment (1993-1998). We interrogated eight SNPs in intron 2 of the FGFR2 gene for 1,676 women who developed breast cancer during trial follow-up (1993-2005). Case-only analyses were used to estimate odds ratios for the DM intervention in relation to SNP genotype. RESULTS:Odds ratios for the DM intervention did not vary significantly with the genotype for any of the eight FGFR2 SNPs (P > or = 0.18). However, odds ratios varied (P < 0.05) with the genotype of six of these SNPs, among women having baseline percent of energy from fat in the upper quartile (> or =36.8%). This variation is most evident for SNP rs3750817, with odds ratios for the DM intervention at 0, 1, and 2 minor SNP alleles of 1.06 [95% confidence intervals (95% CI), 0.80-1.41], 0.53 (95% CI, 0.38-0.74), and 0.62 (95% CI, 0.33-1.15). The nominal significance level for this interaction is P = 0.005, and P = 0.03 following multiple testing adjustment, with most evidence deriving from hormone receptor-positive tumors. CONCLUSION:Invasive breast cancer odds ratios for a low-fat dietary pattern, among women whose usual diets are high in fat, seem to vary with SNP rs3750817 in the FGFR2 gene.
RCT Entities:
BACKGROUND: The Women's Health Initiative dietary modification (DM) trial provided suggestive evidence of a benefit of a low-fat dietary pattern on breast cancer risk, with stronger evidence among women whose baseline diet was high in fat. Single nucleotide polymorphisms (SNP) in the FGFR2 gene relate strongly to breast cancer risk and could influence intervention effects. METHODS: All 48,835 trial participants were postmenopausal and ages 50 to 79 years at enrollment (1993-1998). We interrogated eight SNPs in intron 2 of the FGFR2 gene for 1,676 women who developed breast cancer during trial follow-up (1993-2005). Case-only analyses were used to estimate odds ratios for the DM intervention in relation to SNP genotype. RESULTS: Odds ratios for the DM intervention did not vary significantly with the genotype for any of the eight FGFR2 SNPs (P > or = 0.18). However, odds ratios varied (P < 0.05) with the genotype of six of these SNPs, among women having baseline percent of energy from fat in the upper quartile (> or =36.8%). This variation is most evident for SNP rs3750817, with odds ratios for the DM intervention at 0, 1, and 2 minor SNP alleles of 1.06 [95% confidence intervals (95% CI), 0.80-1.41], 0.53 (95% CI, 0.38-0.74), and 0.62 (95% CI, 0.33-1.15). The nominal significance level for this interaction is P = 0.005, and P = 0.03 following multiple testing adjustment, with most evidence deriving from hormone receptor-positive tumors. CONCLUSION:Invasive breast cancer odds ratios for a low-fat dietary pattern, among women whose usual diets are high in fat, seem to vary with SNP rs3750817 in the FGFR2 gene.
Authors: Laurence S Freedman; Nancy Potischman; Victor Kipnis; Douglas Midthune; Arthur Schatzkin; Frances E Thompson; Richard P Troiano; Ross Prentice; Ruth Patterson; Raymond Carroll; Amy F Subar Journal: Int J Epidemiol Date: 2006-05-03 Impact factor: 7.196
Authors: Ross L Prentice; Ying Huang; David A Hinds; Ulrike Peters; Mary Pettinger; David R Cox; Erica Beilharz; Rowan T Chlebowski; Jacques E Rossouw; Bette Caan; Dennis G Ballinger Journal: Cancer Epidemiol Biomarkers Prev Date: 2009-10-27 Impact factor: 4.254
Authors: Ross L Prentice; Bette Caan; Rowan T Chlebowski; Ruth Patterson; Lewis H Kuller; Judith K Ockene; Karen L Margolis; Marian C Limacher; JoAnn E Manson; Linda M Parker; Electra Paskett; Lawrence Phillips; John Robbins; Jacques E Rossouw; Gloria E Sarto; James M Shikany; Marcia L Stefanick; Cynthia A Thomson; Linda Van Horn; Mara Z Vitolins; Jean Wactawski-Wende; Robert B Wallace; Sylvia Wassertheil-Smoller; Evelyn Whitlock; Katsuhiko Yano; Lucile Adams-Campbell; Garnet L Anderson; Annlouise R Assaf; Shirley A A Beresford; Henry R Black; Robert L Brunner; Robert G Brzyski; Leslie Ford; Margery Gass; Jennifer Hays; David Heber; Gerardo Heiss; Susan L Hendrix; Judith Hsia; F Allan Hubbell; Rebecca D Jackson; Karen C Johnson; Jane Morley Kotchen; Andrea Z LaCroix; Dorothy S Lane; Robert D Langer; Norman L Lasser; Maureen M Henderson Journal: JAMA Date: 2006-02-08 Impact factor: 56.272
Authors: James Y Dai; Benjamin A Logsdon; Ying Huang; Li Hsu; Alexander P Reiner; Ross L Prentice; Charles Kooperberg Journal: Am J Epidemiol Date: 2012-07-06 Impact factor: 4.897
Authors: Rihong Zhai; Yang Zhao; Geoffrey Liu; Monica Ter-Minassian; I-Chen Wu; Zhaoxi Wang; Li Su; Kofi Asomaning; Feng Chen; Matthew H Kulke; Xihong Lin; Rebecca S Heist; John C Wain; David C Christiani Journal: Cancer Date: 2011-07-12 Impact factor: 6.860
Authors: James Y Dai; Jean de Dieu Tapsoba; Matthew F Buas; Lynn E Onstad; David M Levine; Harvey A Risch; Wong-Ho Chow; Leslie Bernstein; Weimin Ye; Jesper Lagergren; Nigel C Bird; Douglas A Corley; Nicholas J Shaheen; Anna H Wu; Brian J Reid; Laura J Hardie; David C Whiteman; Thomas L Vaughan Journal: Cancer Epidemiol Biomarkers Prev Date: 2015-09-16 Impact factor: 4.254
Authors: Daniele Campa; Rudolf Kaaks; Loïc Le Marchand; Christopher A Haiman; Ruth C Travis; Christine D Berg; Julie E Buring; Stephen J Chanock; W Ryan Diver; Lucie Dostal; Agnes Fournier; Susan E Hankinson; Brian E Henderson; Robert N Hoover; Claudine Isaacs; Mattias Johansson; Laurence N Kolonel; Peter Kraft; I-Min Lee; Catherine A McCarty; Kim Overvad; Salvatore Panico; Petra H M Peeters; Elio Riboli; Maria José Sanchez; Fredrick R Schumacher; Guri Skeie; Daniel O Stram; Michael J Thun; Dimitrios Trichopoulos; Shumin Zhang; Regina G Ziegler; David J Hunter; Sara Lindström; Federico Canzian Journal: J Natl Cancer Inst Date: 2011-07-26 Impact factor: 13.506
Authors: Catalin Marian; Heather M Ochs-Balcom; Jing Nie; Bhaskar V Kallakury; Christine B Ambrosone; Maurizio Trevisan; Stephen Edge; Peter G Shields; Jo L Freudenheim Journal: Int J Cancer Date: 2010-11-12 Impact factor: 7.396
Authors: Laura Fejerman; Mariana C Stern; Esther M John; Gabriela Torres-Mejía; Lisa M Hines; Roger K Wolff; Kathy B Baumgartner; Anna R Giuliano; Elad Ziv; Eliseo J Pérez-Stable; Martha L Slattery Journal: Cancer Epidemiol Biomarkers Prev Date: 2015-09-12 Impact factor: 4.254